Home ›
Blog ›
Q&A ›
Documentation for Multiple Research Peptides
What Documentation Should Be Kept When Working With Multiple Research Peptides?
Published 2026-07-13 · REVIVE Peptides Research Desk · 1 min read
Short answer: For each research peptide vial, it's good practice to retain the Certificate of Analysis (CoA) for that specific lot, and to log the reconstitution date, diluent used, and storage conditions — this record-keeping becomes more important, not less, as the number of compounds being handled at once grows.
REVIVE LAB UAE provides a lot-specific Certificate of Analysis on request for every product, documenting molecular weight and HPLC purity for that particular batch. Keeping this on file per vial — rather than assuming all batches of a given compound are identical — is standard practice for any research use.
A simple log tracking reconstitution date, diluent type and volume, and storage location for each vial makes it possible to verify a given solution is still within its expected stability window at any point, rather than relying on memory once several vials are in rotation.
This is general research record-keeping practice, not a regulatory requirement REVIVE LAB UAE imposes — buyers remain responsible for whatever documentation their own institution or research protocol requires.
Research-Use Only Disclaimer: This page is published for laboratory and scientific research information purposes only. Nothing here constitutes medical advice, dosing guidance, or a therapeutic recommendation. Products supplied by REVIVE LAB UAE (revivelab.ae) — where applicable — are sold strictly as reference materials for research use, not for human or veterinary consumption. Buyers and readers are solely responsible for compliance with applicable UAE laws and institutional research ethics requirements.